Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
BioCorRx’s “Beat Addiction Recovery Program” therapy modules will be the central addiction treatment resource offered in Phase I of 2B3D’s VRME launch in January, 2023 Los Angeles, CA, Sept. ...
-
TORONTO, ON, Sept. 26, 2022 (GLOBE NEWSWIRE) -- Titan Medical Inc. (Nasdaq: TMDI; TSX: TMD), a medical device company focused on the development and commercialization of innovative surgical...
-
TORONTO, Sept. 22, 2022 (GLOBE NEWSWIRE) -- Titan Medical Inc. (Nasdaq: TMDI; TSX: TMD), a medical device company focused on the development and commercialization of innovative surgical technologies...
-
New York, Sept. 22, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Virology Specimen Collection Global Market Report 2022" -...
-
TORONTO, Sept. 12, 2022 (GLOBE NEWSWIRE) -- Titan Medical Inc. (Nasdaq: TMDI; TSX: TMD), a medical device company focused on the development and commercialization of innovative surgical technologies...
-
TORONTO, Sept. 06, 2022 (GLOBE NEWSWIRE) -- Titan Medical Inc. (Nasdaq: TMDI; TSX: TMD), a medical technology company focused on single access robotic-assisted surgery (RAS) system, today announced...
-
New York, Aug. 29, 2022 (GLOBE NEWSWIRE) -- Kenneth Research has published a detailed market report on ‘Global Montelukast Intermediate Market’ for the forecast period, i.e. 2022 – 2031, which...
-
TORONTO, Aug. 11, 2022 (GLOBE NEWSWIRE) -- Titan Medical Inc. (Nasdaq: TMDI; TSX: TMD), a medical device company focused on the development and commercialization of innovative surgical technologies...
-
New York, July 26, 2022 (GLOBE NEWSWIRE) -- As per the World Health Organization, around 275 million people, or 5.5% of the world's population between the ages of 15 and 64 years, used drugs at...
-
TORONTO, July 25, 2022 (GLOBE NEWSWIRE) -- Titan Medical Inc. (Nasdaq: TMDI; TSX: TMD), a medical technology company focused on single access robotic-assisted surgery (RAS), today announced that the...